Inhibitors of acetohydroxyacid synthase as promising agents against non-tuberculous mycobacterial diseases
- 13 December 2024
- journal article
- research article
- Published by Springer Nature in The Journal of Antibiotics
- Vol. 78 (3) , 181-189
Abstract
Acetohydroxyacid synthase (AHAS), exclusively present in microorganisms and plants, is a promising target for several herbicides due to its catalytic role in the branched-chain amino acid biosynthetic pathway. Previous studies have shown that K13787, a pyrazolopyrimidine sulfonamide AHAS inhibitor, was moderately effective against pulmonary infection caused by M. tuberculosis and nontuberculous mycobacteria (NTM). In this study, we synthesized various structural derivatives of K13787 based on the molecular docking studies and assessed their MICs against mycobacteria species. Among the synthetic compounds screened, K13787, along with KNT2077 and KNT2099, exhibited inhibitory efficacy against M. avium and M. abscessus, including CLR-resistant NTM species. Notably, these compounds displayed a synergistic effect (FIC ≤ 0.5) when combined with CLR against M. avium and M. abscessus. Our findings suggest that these newly identified AHAS-targeted compounds hold promise as lead candidates for novel antimycobacterial agents against NTM infections. Considering the structure-activity relationship, K13787, KNT2077, and KTN2099 emerge as potential treatments for NTM species.Keywords
Funding Information
- National Research Foundation of Korea (2022R1C1C2011153)
This publication has 28 references indexed in Scilit:
- Treatment outcomes of Mycobacterium avium complex pulmonary disease according to disease severityScientific Reports, 2022
- Sulfonamide drugs: structure, antibacterial property, toxicity, and biophysical interactionsBiophysical Reviews, 2021
- Effects of herbicide on non-target microorganisms: Towards a new class of biomarkers?Science of The Total Environment, 2019
- Update on pulmonary disease due to non-tuberculous mycobacteriaInternational Journal of Infectious Diseases, 2016
- Sulfonylureas Have Antifungal Activity and Are Potent Inhibitors of Candida albicans Acetohydroxyacid SynthaseJournal of Medicinal Chemistry, 2012
- Synthesis and evaluation of novel monosubstituted sulfonylurea derivatives as antituberculosis agentsEuropean Journal of Medicinal Chemistry, 2012
- In vitro and ex vivo activity of new derivatives of acetohydroxyacid synthase inhibitors against Mycobacterium tuberculosis and non-tuberculous mycobacteriaInternational Journal of Antimicrobial Agents, 2008
- Mycobacterium abscessus Chest Wall and Pulmonary Infection in a Cystic Fibrosis Lung Transplant RecipientThe Journal of Heart and Lung Transplantation, 2006
- Characterization of acetohydroxyacid synthase from Mycobacterium tuberculosis and the identification of its new inhibitor from the screening of a chemical libraryFEBS Letters, 2005
- Comparison of methods of interpretation of checkerboard synergy testingDiagnostic Microbiology and Infectious Disease, 2002